Cargando…

Fecal microbiota transplantation does not alter bacterial translocation and visceral adipose tissue inflammation in individuals with obesity

AIMS: Visceral adipose tissue inflammation is a fundamental mechanism of insulin resistance in obesity and type 2 diabetes. Translocation of intestinal bacteria has been suggested as a driving factor for the inflammation. However, although bacterial DNA was detected in visceral adipose tissue of hum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bakker, Guido J., Meijnikman, Abraham S., Scheithauer, Torsten P., Davids, Mark, Aydin, Ömrüm, Boerlage, Thomas C. C., de Brauw, L. Maurits, van de Laar, Arnold W., Gerdes, Victor E., Groen, Albert K., van Raalte, Daniël H., Herrema, Hilde, Nieuwdorp, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804924/ https://www.ncbi.nlm.nih.gov/pubmed/35127122 http://dx.doi.org/10.1002/osp4.545

Ejemplares similares

Compensatory intestinal antibody response against pro-inflammatory microbiota after bariatric surgery
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Compensatory intestinal immunoglobulin response after vancomycin treatment in humans
por: Scheithauer, Torsten P. M., et al.
Publicado: (2021)

Evaluating causality of cellular senescence in non-alcoholic fatty liver disease
por: Meijnikman, Abraham Stijn, et al.
Publicado: (2021)

Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction
por: Scheithauer, Torsten P.M., et al.
Publicado: (2022)

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD
por: Meijnikman, Abraham S., et al.
Publicado: (2021)

Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
por: Koning, Mijra, et al.
Publicado: (2023)

Gut Microbiota as a Trigger for Metabolic Inflammation in Obesity and Type 2 Diabetes
por: Scheithauer, Torsten P. M., et al.
Publicado: (2020)

Type 2 diabetes is associated with increased circulating levels of 3-hydroxydecanoate activating GPR84 and neutrophil migration
por: Mikkelsen, Randi Bonke, et al.
Publicado: (2022)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Attachment style and post-bariatric surgery health behaviours: the mediating role of self-esteem and health self-efficacy
por: Pyykkö, Johanna Eveliina, et al.
Publicado: (2023)

Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
por: Hoozemans, Jacqueline, et al.
Publicado: (2021)

The Gut Microbiome as a Target for the Treatment of Type 2 Diabetes
por: Aydin, Ömrüm, et al.
Publicado: (2018)

A systems biology approach to study non-alcoholic fatty liver (NAFL) in women with obesity
por: Meijnikman, Abraham S., et al.
Publicado: (2022)

Pancreatic (18)F-FDG uptake is increased in type 2 diabetes patients compared to non-diabetic controls
por: Bakker, Guido J., et al.
Publicado: (2019)

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study
por: de Groot, Pieter F., et al.
Publicado: (2017)

Self-organized metabotyping of obese individuals identifies clusters responding differently to bariatric surgery
por: Lappa, Dimitra, et al.
Publicado: (2023)

Psychological functioning and well‐being before and after bariatric surgery; what is the benefit of being self‐compassionate?
por: Pyykkö, Johanna Eveliina, et al.
Publicado: (2021)

Donor metabolic characteristics drive effects of faecal microbiota transplantation on recipient insulin sensitivity, energy expenditure and intestinal transit time
por: de Groot, Pieter, et al.
Publicado: (2020)

The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial)
por: van Rijswijk, A., et al.
Publicado: (2022)

Gut bacteriophage dynamics during fecal microbial transplantation in subjects with metabolic syndrome
por: Manrique, Pilar, et al.
Publicado: (2021)

Phage-microbe dynamics after sterile faecal filtrate transplantation in individuals with metabolic syndrome: a double-blind, randomised, placebo-controlled clinical trial assessing efficacy and safety
por: Wortelboer, Koen, et al.
Publicado: (2023)

Glucose-mediated insulin secretion is improved in FHL2-deficient mice and elevated FHL2 expression in humans is associated with type 2 diabetes
por: Habibe, Jayron J., et al.
Publicado: (2022)

From fecal microbiota transplantation toward next-generation beneficial microbes: The case of Anaerobutyricum soehngenii
por: Wortelboer, Koen, et al.
Publicado: (2022)

Adipose Tissue, Bile Acids, and Gut Microbiome Species Associated With Gallstones After Bariatric Surgery
por: Guman, M.S.S., et al.
Publicado: (2022)

A systems biology approach to understand gut microbiota and host metabolism in morbid obesity: design of the BARIA Longitudinal Cohort Study
por: Van Olden, C. C., et al.
Publicado: (2020)

Effect of Fecal Microbiota Transplantation Combined With Mediterranean Diet on Insulin Sensitivity in Subjects With Metabolic Syndrome
por: Koopen, Annefleur M., et al.
Publicado: (2021)

Causality of small and large intestinal microbiota in weight regulation and insulin resistance
por: Scheithauer, Torsten P.M., et al.
Publicado: (2016)

Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects
por: Bakker, Guido J., et al.
Publicado: (2019)

Challenges and costs of donor screening for fecal microbiota transplantations
por: Bénard, Mèlanie V., et al.
Publicado: (2022)

Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
por: Witjes, Julia J., et al.
Publicado: (2020)

Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome
por: de Jonge, Patrick A., et al.
Publicado: (2022)

Identifying Gut Microbiota associated with Gastrointestinal Symptoms upon Roux-en-Y Gastric Bypass
por: Wijdeveld, Madelief, et al.
Publicado: (2023)

An evaluation of the therapeutic potential of fecal microbiota transplantation to treat infectious and metabolic diseases
por: Groen, Albert K, et al.
Publicado: (2016)

Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
por: Koopen, Annefleur M., et al.
Publicado: (2020)

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes
por: Bénard, Mèlanie V., et al.
Publicado: (2023)

Gastrointestinal symptoms and food intolerance 2 years after laparoscopic Roux‐en‐Y gastric bypass for morbid obesity
por: Boerlage, T. C. C., et al.
Publicado: (2016)

Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial)
por: Boerlage, Thomas C. C., et al.
Publicado: (2017)

Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome
por: van der Vossen, Eduard W. J., et al.
Publicado: (2021)

Pancreatitis following bariatric surgery
por: Baran, Kiran Chandni, et al.
Publicado: (2019)

Drivers and determinants of strain dynamics following fecal microbiota transplantation
por: Schmidt, Thomas S. B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gtm92dmjjr59dpdsrpumdi6fi1